Literature DB >> 20553682

Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation.

Miguel Romero1, Rosario Jiménez, Manuel Sánchez, Rocío López-Sepúlveda, Antonio Zarzuelo, Juan Tamargo, Francisco Pérez-Vizcaíno, Juan Duarte.   

Abstract

ET-1 induces vascular O(2)(*-) production via activation of NADPH oxidase. We have investigated whether c-Src and MAPKs activation are involved in ET-1-induced vascular oxidative response. At 2 h, ET-1 induced an increase in NADPH oxidase-driven O(2)(*-) production in rat isolated aortic rings, which was completely suppressed in PP2 (c-Src inhibitor)-pretreated rings, whereas PP3 (inactive analogue of PP2) was without effect. ET-1 increased the levels of phospho-c-Src, the active form of c-Src, and the phosphorylation of cortactin, a Src-specific substrate. Both c-Src and cortactin phosphorylation induced by ET-1 were prevented by PP2. The increased expression of p47(phox), the main cytosolic subunit of NADPH oxidase, induced by ET-1 was also prevented by PP2. The increased vascular O(2)(*-) production and p47(phox) up-regulation induced by ET-1 was only inhibited in aortic rings coincubated with the ERK1/2 inhibitor, PD98059; being without effects both the p38 MAPK inhibitor, SB203580, and JNK inhibitor, SP600125. Aortic rings incubation with ET-1 increased the phosphorylation of ERK1/2. This effect was suppressed by coincubation with PP2 showing that this event is down-stream of c-Src activation. In conclusion, ET-1 induces NADPH oxidase-driven O(2)(*-) generation through increase of p47(phox) protein expression. The signalling pathway for this effect involves c-Src activation and ERK1/2 phosphorylation. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20553682     DOI: 10.1016/j.atherosclerosis.2010.04.031

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

Review 1.  O-GlcNAcylation: a novel pathway contributing to the effects of endothelin in the vasculature.

Authors:  Victor V Lima; Fernanda R Giachini; David M Hardy; R Clinton Webb; Rita C Tostes
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-11-10       Impact factor: 3.619

2.  Endothelin-1 contributes to endothelial dysfunction and enhanced vasoconstriction through augmented superoxide production in penile arteries from insulin-resistant obese rats: role of ET(A) and ET(B) receptors.

Authors:  A Sánchez; P Martínez; M Muñoz; S Benedito; A García-Sacristán; M Hernández; D Prieto
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

3.  Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.

Authors:  Karla G G Serafim; Suelen A Navarro; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Victor Fattori; Thiago M Cunha; Jose C Alves-Filho; Fernando Q Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-06       Impact factor: 3.000

4.  Obligatory role of intraluminal O2- in acute endothelin-1 and angiotensin II signaling to mediate endothelial dysfunction and MAPK activation in guinea-pig hearts.

Authors:  Emilia Wojtera; Anna Konior; Natalia Fedoryszak-Kuśka; Andrzej Beręsewicz
Journal:  Int J Mol Sci       Date:  2014-10-27       Impact factor: 5.923

5.  Serum Concentrations of Endothelin-1 and Matrix Metalloproteinases-2, -9 in Pre-Hypertensive and Hypertensive Patients with Type 2 Diabetes.

Authors:  Krasimir Kostov; Alexander Blazhev; Milena Atanasova; Anelia Dimitrova
Journal:  Int J Mol Sci       Date:  2016-08-01       Impact factor: 5.923

6.  Endothelin-1 dependent expression of GAG genes involves NOX and p38 mediated Smad linker region phosphorylation.

Authors:  Hossein Babaahmadi-Rezaei; Raafat Mohamed; Parisa Dayati; Reyhaneh Niayesh Mehr; Faezeh Seif; Narges Sharifat; Azam Khedri; Danielle Kamato; Peter J Little
Journal:  Clin Exp Pharmacol Physiol       Date:  2022-05-17       Impact factor: 2.963

7.  Vasomotor regulation of coronary microcirculation by oxidative stress: role of arginase.

Authors:  Lih Kuo; Travis W Hein
Journal:  Front Immunol       Date:  2013-08-19       Impact factor: 7.561

8.  Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway.

Authors:  Roberto Palacios-Ramírez; Raquel Hernanz; Angela Martín; José V Pérez-Girón; María T Barrús; Zoe González-Carnicero; Andrea Aguado; Frederic Jaisser; Ana M Briones; Mercedes Salaices; María J Alonso
Journal:  Sci Rep       Date:  2019-11-11       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.